将抗疟疾药物重新定位为抗癌药物:重点关注塔芬诺基因
Christopher E Barton1, Bailey Blair1, Libby Godo1
1Department of Biology, Belmont University. 1900 Belmont Boulevard, Nashville, TN, 37211, USA.
Experimental cell research
|April 11, 2025
概括
抗疟疾药物,包括tafenoquine,通过降低癌细胞活力和诱导亡,显示出作为抗癌药物的潜力. 削减HMOX-1使细胞对塔芬诺基因敏感,突出其治疗前景.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 药物重新定位为开发新的癌症疗法提供了一种具有成本效益的替代方案.
- 某些抗疟疾化合物已经证明具有抗癌性质.
- 识别现有药物的新应用程序可以加速治疗的开发.
研究的目的:
- 在实验室中研究抗疟疾药物对人类癌细胞的疗效.
- 评估tafenoquine作为一种潜在的抗癌药物.
- 阐明Tafenoquine抗癌作用背后的机制.
主要方法:
- 对抗疟疾化合物的查,以检测它们降低癌细胞活力的能力.
- 对tafenoquine和etoposide的疗效进行比较分析.
- 对tafenoquine诱导的亡和基因表达变化的评估.
- 调查血红素氧酶1 (HMOX-1) 在塔费诺昆的作用机制中的作用.
主要成果:
- 多种抗疟疾药物显著降低了人体癌细胞在培养中的活力.
- 塔芬诺基因在降低癌细胞活力方面表现出与埃托波西德相当的疗效.
- 塔芬诺基因诱导了亡和调节了参与细胞循环停止和死亡的基因.
- 消耗HMOX-1对Tafenoquine的亡效应敏感的癌细胞.
结论:
- 抗疟疾化合物是癌症治疗的一类有前途的药物.
- 塔费诺昆在体外表现出强大的抗癌活性.
- 向HMOX-1可能会提高基于tafenoquine的癌症治疗的疗效.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


